Obesity is associated with low-grade subclinical inflammation, systemic iron deficiency and hypoferremia.
INTRODUCTION
Hepcidin; a 25-amino-acid hepatic antimicrobial peptide, is the central regulator of iron homeostasis (Rochette et al., 2014) and also known as liverexpressed antimicrobial peptide-1 (LEAP-1) (Ganz, 2013) . It has been firstly isolated from plasma by Krause et al. (2000) , then from urine by Park et al. 2002 and named it hepcidin. Hepcidin production is upregulated by inflammation, iron overload, infectious stimuli (Ganz, 2015) , obesity (Nikonorov et al., 201) and insulin (Wang et al., 2014) , whereas; it is downregulated by iron deficiency anemia, hypoxia, pregnancy (Koenig et al., 2014) , insulin resistance (Wang et al., 2014) and erythropoietic activity (Ganz, 2015) . Certain proinflammatory cytokines play a fundamental role in inducing hepcidin gene expression, particularly interleukin-1 (IL-1) and interleukin-6 (IL-6) (Casanovas et al., 2014) . The primary target of hepcidin function is ferroportin which is the only known iron exporter in macrophages, hepatocytes and duodenal enterocytes from blood stream (Ganz and Nemeth, 2012) . Given that obesity is a serious global health challenge with pandemic proportion resulting in significant mortality and morbidity (Lecomti et al., 2015) , it increases adipose tissue (AT) mass accompanied by AT remodeling and macrophages infiltration (Suganami and Ogawa, 2010) . Moreover, obesity has been associated with anemia of chronic disease especially systemic iron deficiency and hypoferremia (Albakri et al., 2014) . Obesity may promote iron deficiency by inhibition of dietary iron uptake from the duodenum, and a condition termed dysmetabolic iron overload syndrome (DIOS), which is characterized by increased serum ferritin concentrations with normal or mildly elevated transferrin saturation in subjects with various components of metabolic syndrome or non alcoholic fatty liver disease, has become the most frequent differential diagnosis for elevated ferritin concentrations (Datz et al., 2013; Dongiovanni et al., 2013) .
Oral iron supplementation and high-iron diet are commonly prescribed for individuals with anemia (Gisbert et al., 2009) . High-iron diet results in decreased adiponectin production in AT leading to decrease insulin sensitivity (Wlazlo et al., 2013) . Furthermore, iron overload leads to AT and endocrine dysfunction (Gabrielsen et al., 2012) . This could affect adipokines secretion and\or interupt insulin signals pathway leading to obesity-related diseases. Hence, the objective of this critical review was to discuss the role iron overload in systemic iron homeostasis, proinflammatory biomarkers and obesity etiopathogenesis.
Iron Homeostasis
Hepcidin is the key regulator of systemic iron homoeostasis (Hentze et al., 2010) . While hepcidin is mainly synthesized in hepatocytes, it is also produced in intestinal cells, pancreatic cells, AT and monocytes (Zhang and Rovin 2010) . The function of hepcidin is initiated by its binding to ferroportin, which is the cellular iron exporter located in the basolateral surface of duodenal enterocytes and on the cellular membrane of macrophages, leading to rapid internalization and degradation of ferroportin (Ghosh et al., 2013) . Thus, high hepcidin levels reduces iron absorption in intestinal enterocytes and prevents the movement of dietary iron into circulation. Moreover, hepcidin prevents the movement of stored iron in macrophages and liver into circulation (Nemeth et al., 2004) . This is mediated by the bone morphogenetic protein (BMP)-SMAD signaling cascade with BMP-6 serving as an iron related BMP-receptor ligand and its up-regulated by iron overload and inflammation (Silvestri et al., 2008) . The rapid sequestration of iron in macrophages and the longterm of reducing enteral iron absorption lead to anemia by decreasing iron availability for erythropoiesis (Babitt et al., 2007) . In contrast, hepcidin expression is suppressed in situations of increased erythropoietic demand, the absence of hepcidin leads to unregulated duodenal iron absorption and subsequent iron overload, which has also been reported in pathological conditions Findings of studies demonstrated that elevated hepcidin levels in inflammation is mediated by increased IL-6 and play a key role in the anemia of inflammation and reticuloendothelial blockade (Park et al., 2006) .
Additionally, leptin, anti-obesity hormone, increases hepcidin expression via the Jak2/STAT3 signaling pathway in parallel with IL-6 (Chung et al., 2007) . 
Pathological Effects of Iron Supplementation
Iron deficiency is the most common cause of anemia worldwide (Gisbert et al., 2009) . Globally, iron deficiency anemia affect more than two billion people especially the children due to their heightened iron requirements (Zimmermann and Hurrell, 2007) . Iron deficiency anemia is associated with a decrease in the cellular immune response, mental function, physical activity, and alterations in hormonal regulation (Viteri et al., 2012) . Therefore oral iron supplementation is commonly prescribed for people diagnosed with anemia (Gisbert et al., 2009) 
Pathological Effects of Iron Overload
Moderately elevated iron levels are associated with chronic diseases such as atherosclerosis, type 2 diabetes mellitus (T2DM) and premature death (Fasola et al., 2013) . DIOS is characterized by increased ferritin levels, and increased body iron stores in the presence of insulin resistance (Dongiovanni et al., 2013) . DIOS was observed in 15% to 30% of individuals with the metabolic syndrome (Valenti et al., 2010) . DIOS with normal or mildly elevated transferrin saturation was observed in approximately a one-third of patients with metabolic syndrome or nonalcoholic fatty liver disease (Aigner et al., 2014) .
In order to protect against invading pathogens during prolonged chronic inflammation infectious or autoimmune disorders, the diversion of iron traffic from circulation into storage sites may limit iron for erythropoiesis even in the presence of adequate stores (local iron overload) (Wrighting and Andrews, 2006; Weinberg, 2009 ). The induction of hepcidin via the IL-6/STAT3 signaling pathway promotes iron retention in macrophages, which decreased dietary iron absorption and hypoferremia leading to anemia of chronic diseases (Weiss and Goodnough, 2005) .
Iron overload can affect major tissues involved in glucose and lipid metabolism as well as organs affected by chronic diabetic complications (Fernandez-Real and Manco, 2014) . Epidemiological studies showed an association between iron stores and the development of metabolic syndrome (Park et al., 2012) . Zheng et al. (2011) noted that liver iron is increased in people with T2DM and insulin resistance. Moreover, increased body iron stores were significantly associated with risk of T2DM (Bao et al., 2012) . Recently, it was reported that the serum concentration of prohepcidin (a precursor of the mature hepcidin) was significantly higher in males with impaired glucose tolerance or T2DM than in those with normal glucose tolerance (Derbent et al., 2013) .
In liver, iron overload can disrupt insulin inhibition of hepatic glucose production, which together with 
Association between Obesity and Inflammation
Obesity is a pandemic health problem associated with low-grade chronic inflammation, (Albakri et al, 2014) . In 2014, more than 1.9 billion adults worldwide were overweight; of these over 600 million were 
Role of Obesity in Iron Homeostasis
Obesity has been associated with anemia of chronic disease especially systemic iron deficiency and hypoferremia (Ghadiri-Anari et al., 2014) and it is well documented to increase hepcidin production and inflammation; this may, in part at least, lead to iron dismetabolism. Table 1 summarizes the association between body weight, inflammation and iron status in human (Table 1) .
Additionally, obesity could increase iron deficiency by inhibition of dietary iron uptake from the duodenum leading to DIOS which has become the most frequent differential diagnosis for elevated ferritin levels (Datz et al., 2013) . Obesity-related hypoferremia could be attributed to obesity-induced inflammatory state produced from the increased hepcidin and lipocalin 2 levels in obese individuals (Nairz et al., 2015) . The coexistence of both lipocalin-2 and hepcidin limit iron availability for bacterial growth; this, increases iron import into the storage cells leading to elevated intracellular iron in obese individuals (Xu et al., 2012) . Thus, IL-4 enhances production of transferrin1 mRNA through a non-iron response proteins dependent pathway and it may serve as a control for both macrophage polarization and iron handling (Hubler et al., 2015) .
Moreover, the expression of heme oxygenase-1, which is an enzyme that metabolizes heme into iron and it is a part of the cellular defense against oxidative stress, has been reduced in MFe hi cells in obese mice (Kovtunovych et al., 2010) . However, heme oxygenase-1 is downregulated by the inflammatory cytokine interferon-γ and upregulated by IL-4 (Sierra-Filardi et al., 2010) .
CONCLUSION
The complex interaction between obesity induced inflammatory state, hypoxia and high iron intake could up-regulate hepcidin and other inflammatory cytokines in adipose tissue, leading to increase oxidative stress and tissue iron overload, which, could affect the pathogenesis of several chronic metabolic diseases. However, this necessities further studies to understand the possible mechanisms that may explain the role of iron status in the pathogenesis of obesity taking in consideration the impact of hepcidin and other inflammatory cytokines effect in different specific tissues. 
